72) ualities, and financial stressors require further research. |
73) delivered, and highlight areas that need further research. |
74) iterature and provide advice on potential further research. |
75) me methods and this is an area in need of further research. |
76) ticle, as well as other possibilities for further research. |
77) his review provides findings that suggest further research. |
78) ll as identify gaps and opportunities for further research. |
79) is needed to identify areas that require further research. |
80) topic, and to elucidate topics requiring further research. |
81) g research on DPHS and identify areas for further research. |
82) nt either in clinical practice or through further research. |
83) and highlights gaps in the literature for further research. |
84) Further studies and validation work are re |
85) Further studies are needed to assess the d |
86) Further studies are needed to clarify the |
87) Further studies are needed to determine th |
88) Further studies are needed to improve the |
89) Further studies are needed, and in a wide |
90) Further studies are required about patient |
91) Further studies are required for using mor |
92) Further studies are required for validatio |
93) Further studies are required to achieve hi |
94) Further studies are required to assess the |
95) Further studies are required to determine |
96) Further studies are warranted to assess th |
97) Further studies can help clarify if these |
98) Further studies may address whether GTT2 i |
99) Further studies need to be conducted using |
100) Further studies of interventions, tested w |
101) Further studies on ultrasonic debridement |
102) Further studies should be carried out to e |
103) Further studies should be performed to val |
104) Further studies using a randomized control |
|